The New York Times @nytimes
Vaccine-resistant Americans are turning to monoclonal antibody treatments with a zeal that has, at times, mystified their doctors, chasing down lengthy infusions after rejecting vaccines that cost one-hundredth as much. https://t.co/GC0hlg8Kai — PolitiTweet.org